Claim it free in under 5 minutes — verified by GSTIN, DigiLocker, or WhatsApp OTP. You control what buyers see, respond to inquiries, and post on RFQs.
Nimbles Biotech has ranked as one the primary pharmaceutical companies in India due to its innovation in pharmaceutical products. While we take pride in our research, our true satisfaction stems from the fact that we take a proactive measure to aid health in the country today. Life is sustained the way it is today due to Scientific Developments. Even though potent and life threatening infections have been eliminated, active lifestyle diseases are now claiming the throne and demanding special innovations and breakthroughs from healthcare. It still remains a challenge not just to provide for absence of disease, but to nurture a state of health that is conducive to physical, mental and social wellbeing. Health Care across the world is shifting its focus to these goals, and India pharmaceutical companies are not far behind. Established in the year 2008 , Nimbles Biotech is a trusted company engaged in manufacturing and trading of a myriad of pharmaceutical drugs. Nimbles Biotech successfully develop and market innovative products that improve enhance and extend human life; and we pride ourselves on delivering total quality products at an affordable price.
Founded Nimbles Biotech in 2008, growing it into a trusted PCD Pharma Franchise. Launched Philanto Wellness in 2024. Drives both companies w…
General Manager of Nimbles Biotech, crucial in driving growth and excellence. Strong background in pharma operations, strategic planning, an…
Anchored to live government registries — MCA, GSTN, DGFT, EPFO. No pay-to-play badges. Refreshed weekly.
Verified across 4 government databases: MCA · Udyam · BharatSeal · EPFO
NIMBLES BIOTECH PRIVATE LIMITED is anchored to the official records above. Anything self-declared by the company is labelled separately on this page. Check another company free →
Other verified manufacturers in the same network — discovered via MCA21 cross-references.